Clinical Trial Update: Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic Sclerosis [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating probiotics for moderate-to-severe distention and bloating in systemic sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: University of Michigan | Conditions: Scleroderma | Phase 4 | Status: WITHDRAWN